
Loading, please wait...

Loading, please wait...

Brachial plexus injuries present significant challenges for functional recovery, often requiring complex nerve transfer surgeries. While surgical techniques have advanced, clinicians still face difficulties in tracking the underlying biological recovery. Recent research highlights how needle electromyography reinnervation monitoring provides a cost-effective and reproducible method to evaluate both axonal growth and cortical changes. This longitudinal study explores the utility of serial EMG in assessing these critical recovery markers.
Traumatic brachial plexus injuries often result in devastating loss of shoulder and elbow function. Consequently, surgeons perform neurotization or nerve transfers to bridge the gap in neural pathways. However, successful outcomes depend on more than just physical axonal regeneration. The brain must also undergo cortical plasticity to adapt to the new donor-recipient relationship. Although advanced neuroimaging can detect these brain changes, its high cost and technical complexity limit its daily clinical use.
Researchers conducted a longitudinal observational study involving 21 patients who underwent 34 proximal nerve transfers between 2012 and 2020. They performed serial electromyography at 3- to 9-month intervals over at least three years. Specifically, the team used dual-channel recordings to monitor spontaneous activity, motor unit potentials, and synkineses.
The results showed that functional success, defined as an MRC score of ≥3/5 with adequate range of motion, occurred in 58.8% of cases. Notably, patients who achieved success displayed early signs of reinnervation within 6.5 months on average. Furthermore, those with successful functional outcomes reached motor unit potential (MUP) stability significantly faster than those with poor results.
In addition to tracking axonal growth, needle electromyography serves as a window into the central nervous system. The study identified synkinetic activity as a crucial marker of neuroplasticity. These synkineses represent the brain's attempt to rewire neural pathways after nerve transfer. Therefore, monitoring these electrical signals allows clinicians to assess whether the patient is successfully integrating the new nerve source into functional movements.
Moreover, the findings suggest that the timing of MUP appearance is a strong predictor of ultimate strength. Clinicians can use these early markers to adjust rehabilitation protocols or consider secondary interventions if reinnervation appears delayed. Ultimately, this approach offers a practical way to bridge the gap between electrophysiological data and clinical functional scores.
Integrating serial needle electromyography into post-operative care provides invaluable data on both nerve regeneration and brain adaptation. By identifying synkineses and monitoring the speed of reinnervation, healthcare providers can better predict and support patient recovery. This method remains a highly accessible and effective tool for surgeons and neurologists managing complex brachial plexus reconstructions.
Early signs of reinnervation typically appear between 6 to 7 months post-surgery. However, the exact timing varies based on the distance between the donor nerve and the target muscle.
Synkineses are involuntary muscle contractions that occur alongside voluntary movements. In nerve transfers, they act as potential markers of neuroplasticity, indicating that the brain is adapting to the new neural connections.
Functional recovery requires the brain to learn how to control a muscle using a different donor nerve. Without this cortical adaptation, even successful physical nerve growth may not lead to coordinated functional movement.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
1. Brušáková Š et al. Monitoring Reinnervation and Neuroplasticity After Neurotization Using Needle Electromyography. J Clin Neurophysiol. 2026 Feb 12. doi: 10.1097/WNP.0000000000001243. PMID: 41678273.
2. Bhandari PS et al. Surgical outcomes following nerve transfers in upper brachial plexus injuries. Indian J Plast Surg. 2009;42:150–60. doi: 10.4103/0970-0358.59272.
3. Sulaiman O et al. Nerve transfer surgery for adult brachial plexus injury: a 10-year experience at Louisiana State University. Neurosurgery. 2009.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


This study explores needle electromyography as a reproducible tool to monitor reinnervation and cortical plasticity after nerve transfers for brachial plexu...
6 months ago

The Delhi government and DSACS have launched a two-month intensified HIV awareness initiative targeting youth, schools, and local communities. The drive strengthens decentralized testing, expands antiretroviral therapy linkages, ensures legal safeguards under the HIV Act 2017, and provides crucial financial aid.
Today

A multicenter MPOG database study of 289,047 cesarean delivery cases analyzed adherence to obstetric anesthesia best practices. General anesthesia avoidance reached 97.0%, while post-spinal vasopressor infusions (55.4%) and hypothermia prevention (56.7%) showed the lowest compliance, highlighting key targets.
Yesterday

A comprehensive meta-analysis shows digital health technologies significantly improve 6-minute walk distance and peak oxygen uptake in chronic heart failure patients, highlighting the clinical promise of structured remote cardiac rehabilitation.
Today

Recent research assesses an automated pipeline for CT-based vertebral finite element analysis, revealing how boundary condition components—especially load-point assignment—impact fracture-load accuracy in spinal biomechanics.
Today

A comprehensive analysis of continuous glucose monitoring systems under European Medical Device Regulation 2017/745, examining conformity assessment challenges, Notified Body backlogs, EUDAMED rollout delays, and the critical need for transparent post-market surveillance.
Today